Nisa Investment Advisors’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$24.2M Sell
337,119
-25,976
-7% -$2M 0.09% 139
2025
Q4
$28.8M Buy
363,095
+19,709
+6% +$1.55M 0.1% 127
2025
Q3
$25.9M Buy
343,386
+4,555
+1% +$312K 0.1% 135
2025
Q2
$23.4M Buy
338,831
+7,333
+2% +$481K 0.11% 145
2025
Q1
$22.5M Buy
331,498
+26,981
+9% +$1.61M 0.11% 157
2024
Q4
$13.7M Sell
304,517
-9,507
-3% -$533K 0.05% 244
2024
Q3
$19.7M Sell
314,024
-27,272
-8% -$1.59M 0.12% 169
2024
Q2
$20.2M Sell
341,296
-18,382
-5% -$1.15M 0.13% 165
2024
Q1
$28.7M Sell
359,678
-8,427
-2% -$644K 0.19% 119
2023
Q4
$29.1M Buy
368,105
+1,956
+0.5% +$139K 0.21% 111
2023
Q3
$25.6M Sell
366,149
-2,810
-0.8% -$199K 0.2% 118
2023
Q2
$25.5M Sell
368,959
-17,601
-5% -$1.25M 0.19% 116
2023
Q1
$28.7M Buy
386,560
+677
+0.2% +$56.8K 0.23% 101
2022
Q4
$36M Sell
385,883
-22,685
-6% -$2.19M 0.28% 81
2022
Q3
$39M Buy
408,568
+21,309
+6% +$2.11M 0.33% 63
2022
Q2
$35.9M Sell
387,259
-3,495
-0.9% -$341K 0.31% 66
2022
Q1
$39.5M Buy
390,754
+10,662
+3% +$1.12M 0.28% 77
2021
Q4
$40.5M Buy
380,092
+4,417
+1% +$408K 0.3% 78
2021
Q3
$31.9K Buy
375,675
+3,765
+1% +$315K 0.19% 106
2021
Q2
$31K Sell
371,910
-42,205
-10% -$3.46M 0.19% 103
2021
Q1
$31.2K Sell
414,115
-4,930
-1% -$359K 0.2% 99
2020
Q4
$28.6M Buy
419,045
+2,055
+0.5% +$134K 0.18% 130
2020
Q3
$24.4M Buy
416,990
+1,310
+0.3% +$81.5K 0.2% 119
2020
Q2
$27M Sell
415,680
-9,315
-2% -$587K 0.25% 89
2020
Q1
$25.2M Buy
424,995
+25,909
+6% +$1.73M 0.28% 84
2019
Q4
$29.6M Sell
399,086
-1,750
-0.4% -$123K 0.25% 87
2019
Q3
$25.3M Sell
400,836
-40,211
-9% -$2.38M 0.22% 99
2019
Q2
$24M Sell
441,047
-60,242
-12% -$3.24M 0.23% 96
2019
Q1
$27M Sell
501,289
-29,344
-6% -$1.81M 0.26% 86
2018
Q4
$34.8M Buy
530,633
+76,115
+17% +$5.68M 0.39% 58
2018
Q3
$35.8M Buy
454,518
+21,749
+5% +$1.55M 0.33% 67
2018
Q2
$27.9M Buy
432,769
+27,559
+7% +$1.82M 0.29% 78
2018
Q1
$25.7M Sell
405,210
-42,105
-9% -$3.02M 0.27% 83
2017
Q4
$32.4M Sell
447,315
-22,913
-5% -$1.67M 0.33% 63
2017
Q3
$38.2M Buy
470,228
+28,021
+6% +$2.22M 0.43% 50
2017
Q2
$35.4M Sell
442,207
-5,787
-1% -$457K 0.42% 51
2017
Q1
$35.2M Buy
447,994
+32,868
+8% +$2.62M 0.42% 46
2016
Q4
$32.8M Buy
415,126
+9,839
+2% +$796K 0.4% 50
2016
Q3
$36.1M Sell
405,287
-7,319
-2% -$691K 0.47% 46
2016
Q2
$39.5M Buy
412,606
+13,948
+3% +$1.39M 0.53% 41
2016
Q1
$41.4M Sell
398,658
-1,400
-0.3% -$136K 0.59% 35
2015
Q4
$39.1M Buy
400,058
+1,600
+0.4% +$157K 0.56% 37
2015
Q3
$38.6M Sell
398,458
-11,983
-3% -$1.26M 0.59% 34
2015
Q2
$43M Sell
410,441
-50,774
-11% -$5.19M 0.61% 33
2015
Q1
$47.6M Sell
461,215
-23,350
-5% -$2.36M 0.66% 29
2014
Q4
$46.7M Sell
484,565
-10,035
-2% -$884K 0.64% 31
2014
Q3
$39.4M Sell
494,600
-1,850
-0.4% -$146K 0.55% 37
2014
Q2
$37.4M Sell
496,450
-20,335
-4% -$1.54M 0.52% 38
2014
Q1
$38.7M Sell
516,785
-5,922
-1% -$418K 0.55% 36
2013
Q4
$37.4M Sell
522,707
-24,236
-4% -$1.56M 0.53% 39
2013
Q3
$31M Sell
546,943
-13,845
-2% -$825K 0.48% 45
2013
Q2
$32.1M Buy
+560,788
New +$32.5M 0.5% 41

Other funds holding CVS

Nisa Investment Advisors's CVS Position: Q1 2026 in Review

Nisa Investment Advisors reduced its CVS Health (CVS) stake by 7.2% in Q1 2026, selling an estimated $2M and leaving 337,119 shares worth $24.2M. The position accounts for 0.09% of the portfolio, ranked #139.

Nisa Investment Advisors first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $47.6M in Q1 2015. 1,873 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Nisa Investment Advisors held 337,119 shares of CVS Health worth $24.2M as of Q1 2026.
  • Nisa Investment Advisors sold 25,976 CVS Health shares in Q1 2026, an estimated $2M.
  • CVS Health made up 0.09% of Nisa Investment Advisors's portfolio in Q1 2026, its #139 holding.
  • Nisa Investment Advisors first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
  • Nisa Investment Advisors's CVS Health position peaked at $47.6M in Q1 2015.
  • 1,873 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.